Home » Health Care

Press Releases

PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA Statement
October 1 2012

Pharmaceutical Research and Manufacturers of America PhRMA President and CEO John J....

BIO Commends Senate for Approval of User Fee Package
June 27 2012

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Hails House Passage of Reconciled User Fee Package
June 21 2012

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Lauds Senate Passage of User Fee Package
May 24 2012

BIO commends the bipartisan Senate approval of FDASIA, which includes a reauthorization of the...

2012 BIO International Convention to Highlight the FDA and Regulatory Environment
May 9 2012

Global event for biotechnology to be held June 18-21, 2012 in Boston.

BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012

Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization...

BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations
February 1 2012

In the testimony, Richard Pops, Alkermes plc Chairman and CEO,  stressed the...

BIO Urges Congress to Promptly Reauthorize PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients
January 13 2012

BIO strongly supports the PDUFA V recommendations as they will enhance the drug development...

BIO Expresses Strong Support for Timely Reauthorization of PDUFA
October 24 2011

In a public meeting hosted by FDA, BIO  expressed strong support for the PDUFA V...

BIO Supports Timely Reauthorization of PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients
September 1 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Celebrates Senate Passage of PDUFA Reauthorization Package
September 21 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

BIO Commends House for Approving PDUFA Reauthorization Package
September 19 2007

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

Recommended Improvements to Prescription Drug User Fee Program Will Improve Drug Safety
January 11 2007

The recommended improvements to the Prescription Drug User Fee Act (PDUFA) announced today by...

House Passes Bioterrorism/PDUFA Legislation in 425-1 Vote
May 22 2002

The House of Representatives today voted 425-1 to approve “The Public Health Security...

BIO President Addresses FDA on PDUFA
September 18 2000

Press Releases

PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA Statement
October 1 2012
Pharmaceutical Research and Manufacturers of America PhRMA President and CEO John J. Castellani and BIO President and CEO Jim Greenwood released the following joint statement on the implementation of the Prescription Drug User Fee Act (PDUFA V).
BIO Commends Senate for Approval of User Fee Package
June 27 2012
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate.
BIO Hails House Passage of Reconciled User Fee Package
June 21 2012
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on unanimous passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. House of Representatives.
BIO Lauds Senate Passage of User Fee Package
May 24 2012
BIO commends the bipartisan Senate approval of FDASIA, which includes a reauthorization of the Prescription Drug User Fee Act (PDUFA).  
2012 BIO International Convention to Highlight the FDA and Regulatory Environment
May 9 2012
Global event for biotechnology to be held June 18-21, 2012 in Boston.
More Press Releases →